Reduced levels of vesicular glutamate transporter 1 (VGLUT1) have been linked to reduced efficiency of glutamate metabolism, and have been described in animal models, as well as in patients with AD, correlating with memory impairment [151,152], (Figure 2). This evidence concerns the gene SLC17A7 and Alzheimer disease.